Crossref journal-article
Proceedings of the National Academy of Sciences
Proceedings of the National Academy of Sciences (341)
Abstract

Mutations in Btk result in the B cell immunodeficiencies X-linked agammaglobulinemia (XLA) in humans and X-linked immunodeficiency (xid) in mice. Btk is a critical component of signaling pathways regulating B cell development and function. We used a genetic approach to determine whether Btk is also limiting for these processes. One allele of a murine Btk transgene expressed a dosage of Btk (25% of endogenous levels in splenic B cells) sufficient to restore normal numbers of phenotypically mature conventional B cells in xid mice. 2,4,6-trinitrophenyl–Ficoll response, anti-IgM-induced proliferation, B1 cell development, and serum IgM and IgG3levels remained significantly impaired in these animals. B cells from Btk −/− transgenic mice also responded poorly to anti-IgM, indicating that the xid mutation does not create a dominant negative form of Btk. Response to 2,4,6-trinitrophenyl–Ficoll and B cell receptor cross-linking were increased 3- to 4-fold in xid mice homozygous for the transgene. These results demonstrate that Btk is a limiting component of B cell antigen receptor signaling pathways and suggest that B cell development and response to antigen may require different levels of Btk activity.

Bibliography

Satterthwaite, A. B., Cheroutre, H., Khan, W. N., Sideras, P., & Witte, O. N. (1997). Btk dosage determines sensitivity to B cell antigen receptor cross-linking. Proceedings of the National Academy of Sciences, 94(24), 13152–13157.

Authors 5
  1. Anne B. Satterthwaite (first)
  2. Hilde Cheroutre (additional)
  3. Wasif N. Khan (additional)
  4. Pascalis Sideras (additional)
  5. Owen N. Witte (additional)
References 63 Referenced 83
  1. 10.1073/pnas.93.6.2264
  2. 10.1126/science.1373518
  3. 10.1016/1074-7613(95)90157-4
  4. F E Lund, N Yu, K-M Kim, M Reth, M C Howard J Immunol 157, 1455–1467 (1996). (10.4049/jimmunol.157.4.1455) / J Immunol by Lund F E (1996)
  5. A Pezzutto, P S Rabinovitch, B Dorken, G Moldenhauer, E A Clark J Immunol 140, 1791–1795 (1988). (10.4049/jimmunol.140.6.1791) / J Immunol by Pezzutto A (1988)
  6. 10.1126/science.7618087
  7. 10.1016/S0960-9822(06)00057-1
  8. 10.1126/science.274.5288.798
  9. 10.1038/384634a0
  10. 10.1016/S1074-7613(00)80270-8
  11. 10.1016/1074-7613(95)90075-6
  12. 10.1126/science.7716523
  13. 10.1084/jem.181.6.2077
  14. 10.1038/381325a0
  15. 10.1016/0092-8674(93)90667-F
  16. 10.1038/361226a0
  17. 10.1126/science.8332901
  18. 10.1126/science.8332900
  19. D Campana, J Farrant, N Inamdar, A D B Webster, G Janossy J Immunol 145, 1675–1680 (1990). (10.4049/jimmunol.145.6.1675) / J Immunol by Campana D (1990)
  20. 10.1542/peds.9.6.722
  21. 10.1093/nar/25.1.166
  22. 10.1016/1074-7613(95)90115-9
  23. 10.1016/1074-7613(95)90114-0
  24. 10.1002/j.1460-2075.1996.tb00867.x
  25. 10.1038/306270a0
  26. 10.1084/jem.147.3.814
  27. 10.1093/intimm/5.9.1183
  28. 10.1084/jem.172.6.1625
  29. 10.1093/intimm/7.2.163
  30. 10.1182/blood.V85.3.627.bloodjournal853627
  31. 10.1128/mcb.14.8.5108-5113.1994
  32. 10.1084/jem.149.4.993
  33. 10.1084/jem.142.3.637
  34. 10.1002/eji.1830160423
  35. E F Faust, D J Rawlings, D C Saffran, O N Witte Contemporary Topics in Microbiology and Immunology: Mechanisms in B-Cell Neoplasia, eds M Potter, F Melchers (Springer, Berlin) 1, 363–370 (1994). / Contemporary Topics in Microbiology and Immunology: Mechanisms in B-Cell Neoplasia by Faust E F (1994)
  36. 10.1073/pnas.94.2.610
  37. 10.1084/jem.177.2.305
  38. 10.1128/mcb.9.5.1866-1874.1989
  39. 10.1016/0092-8674(93)90111-3
  40. 10.1126/science.271.5250.822
  41. 10.1084/jem.151.1.224
  42. M J Bykowsky, R N Haire, Y Ohta, H Tang, S S Sung, E S Veksler, J M Greene, S M Fu, G W Litman, K E Sullivan Am J Hum Genet 58, 477–483 (1996). / Am J Hum Genet by Bykowsky M J (1996)
  43. R T Woodland, M R Schmidt, S J Korsmeyer, K A Gravel J Immunol 156, 2143–2154 (1996). (10.4049/jimmunol.156.6.2143) / J Immunol by Woodland R T (1996)
  44. 10.1016/S1074-7613(00)80418-5
  45. 10.1126/science.273.5276.788
  46. 10.1084/jem.185.6.981
  47. 10.1073/pnas.81.8.2494
  48. 10.1002/eji.1830170414
  49. 10.1084/jem.175.5.1213
  50. 10.1084/jem.152.5.1194
  51. 10.1016/0008-8749(82)90325-2
  52. 10.1128/MCB.16.7.3465
  53. 10.1128/MCB.15.10.5304
  54. 10.1073/pnas.91.23.11256
  55. 10.1016/S0021-9258(17)34048-6
  56. 10.1073/pnas.92.19.8601
  57. 10.1073/pnas.91.19.9175
  58. 10.1084/jem.150.1.31
  59. 10.1172/JCI110651
  60. C L Scribner, C T Hansen, D M Klinman, A D Steinberg J Immunol 138, 3611–3617 (1987). (10.4049/jimmunol.138.11.3611) / J Immunol by Scribner C L (1987)
  61. 10.1016/S1074-7613(00)80511-7
  62. 10.1084/jem.184.3.831
  63. 10.1084/jem.177.3.857
Dates
Type When
Created 23 years, 1 month ago (July 26, 2002, 10:32 a.m.)
Deposited 2 years, 4 months ago (April 22, 2023, 8:11 a.m.)
Indexed 1 week, 1 day ago (Aug. 24, 2025, 6:50 p.m.)
Issued 27 years, 9 months ago (Nov. 25, 1997)
Published 27 years, 9 months ago (Nov. 25, 1997)
Published Online 27 years, 9 months ago (Nov. 25, 1997)
Published Print 27 years, 9 months ago (Nov. 25, 1997)
Funders 0

None

@article{Satterthwaite_1997, title={Btk dosage determines sensitivity to B cell antigen receptor cross-linking}, volume={94}, ISSN={1091-6490}, url={http://dx.doi.org/10.1073/pnas.94.24.13152}, DOI={10.1073/pnas.94.24.13152}, number={24}, journal={Proceedings of the National Academy of Sciences}, publisher={Proceedings of the National Academy of Sciences}, author={Satterthwaite, Anne B. and Cheroutre, Hilde and Khan, Wasif N. and Sideras, Pascalis and Witte, Owen N.}, year={1997}, month=nov, pages={13152–13157} }